🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The FAVOR V AMI study is a prospective, multicenter, blinded, randomized, s...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-09-30
Trial ID
NCT05669222
Treatments Being Tested
Quantitative flow reserve (QFR), derived from coronary angiography, has sho...
Status
Completed
Location
Zhongshan Hospital, Fudan University
Start Date
2018-07-01
Trial ID
NCT06322355
Treatments Being Tested
The overall purpose of the FAVOR III China trial is to investigate if a str...
Status
Unknown
Location
Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences
Start Date
2018-12-25
Trial ID
NCT03656848
Treatments Being Tested
1. to investigate the feasibility and diagnostic performance of contrast qu...
Status
Completed
Location
Keimyung University Dongsan Medical Center
Start Date
2016-04-30
Trial ID
NCT03791788
Treatments Being Tested
Coronary microcirculation disorder refers to a disease in which small blood...
Status
Enrolling By Invitation
Location
Department of Cardiology, Shaanxi Provincial People's Hospital
Start Date
2025-02-28
Trial ID
NCT07074847
Treatments Being Tested
Prospective intervention study to assess the accuracy of the predicted QFR-...
Status
Unknown
Location
Complejo Hospitalario Universitario, Santiago de Compostela
Start Date
2020-01-01
Trial ID
NCT04200469
Treatments Being Tested
Reliability of 3D angio QFR functional evaluation of all non culprit lesion...
Status
Unknown
Location
Azienda Ospedaliera Sant-Anna e San Sebastiano
Start Date
2016-11
Trial ID
NCT02998853
Treatments Being Tested
1. The primary technical endpoint was the diagnostic performance of the QFR...
Status
Completed
Location
Seoul Saint Mary's Hospital
Start Date
2012-01-01
Trial ID
NCT04102917
Treatments Being Tested